Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer

A. Socinski, Mark; M. Jotte, Robert; Cappuzzo, Federico; Nishio, Makoto; S. K. Mok, Tony; Reck, Martin; G. Finley, Gene; D. Kaul, Monika; Yu, Wei; Paranthaman, Nindhana; Bāra, Ilze; J. West, Howard

doi:10.1001/jamaoncol.2022.7711

Public

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer

Shared by NobleBlocks on Apr 1, 2023 • 12:00 AM UTC

Authors:

Mark A. Socinski

Robert M. Jotte

Federico Cappuzzo

Abstract

Importance Immune-related adverse events (irAEs) arising from immune checkpoint inhibitor (ICI) cancer therapy may potentially predict improved outcomes. Objective To evaluate the association between irAEs and atezolizumab efficacy in patients with advanced non–small cell lung cancer (NSCLC) using p...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!